Prior antimicrobial therapy duration influences causative pathogens identification in ventilator-associated pneumonia
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Journal of Critical Care
- Vol. 43, 375-377
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016Critical Care Medicine, 2017
- Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic SocietyClinical Infectious Diseases, 2016
- Preventive and therapeutic strategies in critically ill patients with highly resistant bacteriaIntensive Care Medicine, 2015
- Microbial Persistence and the Road to Drug ResistanceCell Host & Microbe, 2013
- Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumoniaCritical Care, 2008
- Antibiotic Utilization and Outcomes for Patients With Clinically Suspected Ventilator-Associated Pneumonia and Negative Quantitative BAL Culture ResultsChest, 2005
- Clinical Importance of Delays in the Initiation of Appropriate Antibiotic Treatment for Ventilator-Associated PneumoniaChest, 2002
- Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumoniaEuropean Respiratory Journal, 2002
- Pneumonia in Intubated Patients: Role of Respiratory Airway CareAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Diagnosis of Ventilator-associated Pneumonia by Bacteriologic Analysis of Bronchoscopic and Nonbronchoscopic “Blind” Bronchoalveolar Lavage FluidAmerican Review of Respiratory Disease, 1991